The role of the urinary microbiome in diabetes-associated UTIs: current understanding and future directions
Journal of Basic and Clinical Physiology and Pharmacology · 2026
DOI: 10.1515/jbcpp-2025-0116 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Basic and Clinical Physiology and Pharmacology, 2026. Verfasst von Meenakshi Reddy Yathindra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Mangalore, India. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Microbiota, Urinary Tract Infections, Urinary Tract. Die Arbeit nennt 99 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
This review explores the interplay between type 2 diabetes mellitus (T2DM) and urinary microbiome dysbiosis, focusing on its role in urinary tract infections (UTIs). Once considered sterile, the urinary tract hosts a diverse microbiota that supports mucosal immunity and pathogen resistance. In T2DM, chronic hyperglycemia and glycosuria disrupt microbial balance, impair immune responses, and increase UTI susceptibility. Glycosuria promotes pathogenic colonization, biofilm formation, and microbial shifts, with studies reporting a threefold rise in Escherichia coli and a 56 % reduction in Lactobacillus spp. in diabetic women with recurrent UTIs. Diabetic urine shows reduced diversity, higher abundance of Klebsiella , Pseudomonas , and Enterococcus , and elevated IL-8. Microbiota-targeted interventions, including probiotics ( Lactobacillus crispatus , Lactobacillus rhamnosus GR-1), prebiotics (astaxanthin), and phytotherapeutics (cranberry), demonstrate potential via lactic acid, hydrogen peroxide production, competitive exclusion, and NF-κB modulation. A 12-month RCT showed significant UTI recurrence reduction with probiotics. Advances in 16 S rRNA sequencing and metagenomics reveal microbial signatures associated with diabetic UTIs, though methodological heterogeneity limits comparability. A review of 1,200 publications (2000–2024) highlights the need for longitudinal studies and precision microbiota therapeutics to translate findings into clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Mangalore, India.
- Department of General Medicine, 28577 Gandhi Medical College, Kaloji Narayana Rao University , Hyderabad, India.
- Buddha Hospital and Trauma Centre, Civil Lines, India.
- G.S.L Medical College, Rajamahendravaram, Andhra Pradesh, India.
- Department of General Medicine, Kamineni Institute of Medical Sciences, KNR University, Nalgonda, Telangana, India.
- Department of Nursing, Manipal College of Nursing, Manipal Academy of Higher Education, Manipal, Karnataka, India.
ORCID-Profile: Rithvika Badugu
Zitieren
APA
Yathindra, M. R., Badugu, R., Singh, S. K., Paluri, S., Poudala, H., & Swathi, N. L. (2026). The role of the urinary microbiome in diabetes-associated UTIs: current understanding and future directions. Journal of Basic and Clinical Physiology and Pharmacology. https://doi.org/10.1515/jbcpp-2025-0116
Vancouver
Yathindra MR, Badugu R, Singh SK, Paluri S, Poudala H, Swathi NL. The role of the urinary microbiome in diabetes-associated UTIs: current understanding and future directions. Journal of Basic and Clinical Physiology and Pharmacology. 2026. doi:10.1515/jbcpp-2025-0116
BibTeX
@article{Yathindra2026,
author = {Yathindra, Meenakshi Reddy and Badugu, Rithvika and Singh, Shaurya Kumar and Paluri, Sowthrisha and Poudala, Hrudai and Swathi, Naraginti Leninbabu},
title = {The role of the urinary microbiome in diabetes-associated UTIs: current understanding and future directions},
journal = {Journal of Basic and Clinical Physiology and Pharmacology},
year = {2026},
doi = {10.1515/jbcpp-2025-0116}
}
EUVIMED